Abstract:A few decades ago, drug discovery and development were limited to a bunch of medicinal chemists working in a lab with enormous amount of testing, validations, and synthetic procedures, all contributing to considerable investments in time and wealth to get one drug out into the clinics. The advancements in computational techniques combined with a boom in multi-omics data led to the development of various bioinformatics/pharmacoinformatics/cheminformatics tools that have helped speed up the drug development process. But with the advent of artificial intelligence (AI), machine learning (ML) and deep learning (DL), the conventional drug discovery process has been further rationalized. Extensive biological data in the form of big data present in various databases across the globe acts as the raw materials for the ML/DL-based approaches and helps in accurate identifications of patterns and models which can be used to identify therapeutically active molecules with much fewer investments on time, workforce and wealth. In this review, we have begun by introducing the general concepts in the drug discovery pipeline, followed by an outline of the fields in the drug discovery process where ML/DL can be utilized. We have also introduced ML and DL along with their applications, various learning methods, and training models used to develop the ML/DL-based algorithms. Furthermore, we have summarized various DL-based tools existing in the public domain with their application in the drug discovery paradigm which includes DL tools for identification of drug targets and drug–target interaction such as DeepCPI, DeepDTA, WideDTA, PADME DeepAffinity, and DeepPocket. Additionally, we have discussed various DL-based models used in protein structure prediction, de novo design of new chemical scaffolds, virtual screening of chemical libraries for hit identification, absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, metabolite prediction, clinical trial design, and oral bioavailability prediction. In the end, we have tried to shed light on some of the successful ML/DL-based models used in the drug discovery and development pipeline while also discussing the current challenges and prospects of the application of DL tools in drug discovery and development. We believe that this review will be useful for medicinal and computational chemists searching for DL tools for use in their drug discovery projects.

Deep learning tools to accelerate antibiotic discovery

A Comprehensive Guide to Enhancing Antibiotic Discovery Using Machine Learning Derived Bio-computation

Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii

Discovery of a structural class of antibiotics with explainable deep learning

Deep Neural Networks in the Discovery of Novel Antibiotics Drug Molecule: A Review

Deep Learning Unravels Potential Antibiotic-Resistance Drugs against Klebsiella Pneumoniae

Pre-trained molecular representations enable antimicrobial discovery

Machine learning for antimicrobial peptide identification and design

Applying Machine Learning for Antibiotic Development and Prediction of Microbial Resistance

Machine Learning in Antibacterial Drug Design

Deep-learning-enabled antibiotic discovery through molecular de-extinction

The rise of deep learning in drug discovery

Recent Progress in the Discovery and Design of Antimicrobial Peptides Using Traditional Machine Learning and Deep Learning

Deep learning improves antimicrobial peptide recognition

A machine learning model trained on a high-throughput antibacterial screen increases the hit rate of drug discovery

A high-throughput phenotypic screen combined with an ultra-large-scale deep learning-based virtual screening reveals novel scaffolds of antibacterial compounds

Deep learning tools for advancing drug discovery and development

FIAMol-AB: A feature fusion and attention-based deep learning method for enhanced antibiotic discovery

Predicting antimicrobial class specificity of small molecules using machine learning

Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations

Deep Learning with Evolutionary Scale Modeling to discover Antibiotic-Resistance Drug against Klebsiella Pneumoniae